Q2 2026 Quarterly Financial Results: Filing reports second quarter 2026 performance for Eastman Chemical Company across four operating segments—Advanced Materials, Additives & Functional Products, Chemical Intermediates, and Fibers—with total operating segment sales of $2,510 million and adjusted EBIT of $354 million Segment Performance Breakdown: Advanced Materials generated $817 million in…

Our analysis rates this filing CAUTIOUS. The elevated concern level (5.8/10) reflects a mixed but cautious picture. While consolidated Adjusted EBIT grew 9% YoY and the company maintains solid absolute profitability, multiple concerning signals warrant investor caution. The extreme volatility in…

Concern level: ELEVATED (5.8/10). Key factors: Chemical Intermediates segment shows extreme volatility with $88M swing in EBIT (-$30M Q2 2025 to +$58M Q2 2026), creating earnings unpredictability and suggesting either significant one-time charges or highly cyclical market exposure; Three new risks identified with average severity of 5/10: profitability decline in Chemical Intermediates (severity…

Notable risk changes: Chemical Intermediates segment profitability collapsed in Q2 2025 (-$30M EBIT) but recovered sharply in Q2 2026 (+$58M), indicating extreme cyclicality or one-time charges that create earnings unpredictability; Total segment Adjusted EBIT increased 9% YoY ($354M vs $325M) but this masks significant segment-level volatility and deterioration in Advanced Materials and Fibers segments;…

Not disclosed in provided excerpt.

The model predicts EMN will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.